Charles Schwab’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.5M | Buy |
904,337
+255,927
| +39% | +$2.96M | ﹤0.01% | 1989 |
|
|
2025
Q1 | $5.66M | Buy |
648,410
+108,744
| +20% | +$949K | ﹤0.01% | 2217 |
|
|
2024
Q4 | $7.75M | Sell |
539,666
-111,916
| -17% | -$1.61M | ﹤0.01% | 2130 |
|
|
2024
Q3 | $14.7M | Sell |
651,582
-313,100
| -32% | -$7.07M | ﹤0.01% | 1858 |
|
|
2024
Q2 | $18.8M | Buy |
964,682
+20,325
| +2% | +$395K | ﹤0.01% | 1718 |
|
|
2024
Q1 | $35.4M | Buy |
944,357
+19,525
| +2% | +$733K | 0.01% | 1243 |
|
|
2023
Q4 | $51.8M | Buy |
924,832
+32,709
| +4% | +$1.83M | 0.01% | 955 |
|
|
2023
Q3 | $36.8M | Buy |
892,123
+113,651
| +15% | +$4.69M | 0.01% | 1101 |
|
|
2023
Q2 | $43.5M | Buy |
778,472
+19,425
| +3% | +$1.08M | 0.01% | 949 |
|
|
2023
Q1 | $42.3M | Sell |
759,047
-2,589
| -0.3% | -$144K | 0.01% | 951 |
|
|
2022
Q4 | $27.8M | Buy |
761,636
+30,002
| +4% | +$1.09M | 0.01% | 1196 |
|
|
2022
Q3 | $20.8M | Buy |
731,634
+205,870
| +39% | +$5.86M | 0.01% | 1353 |
|
|
2022
Q2 | $23.8M | Buy |
525,764
+23,494
| +5% | +$1.06M | 0.01% | 1268 |
|
|
2022
Q1 | $38.2M | Buy |
502,270
+10,014
| +2% | +$762K | 0.01% | 1059 |
|
|
2021
Q4 | $73.3M | Buy |
492,256
+17,092
| +4% | +$2.55M | 0.02% | 681 |
|
|
2021
Q3 | $69.2M | Sell |
475,164
-75,925
| -14% | -$11.1M | 0.02% | 674 |
|
|
2021
Q2 | $108M | Buy |
551,089
+22,515
| +4% | +$4.41M | 0.04% | 461 |
|
|
2021
Q1 | $95.7M | Buy |
528,574
+70,889
| +15% | +$12.8M | 0.04% | 473 |
|
|
2020
Q4 | $64.8M | Buy |
457,685
+28,922
| +7% | +$4.1M | 0.03% | 632 |
|
|
2020
Q3 | $53.5M | Buy |
428,763
+371,470
| +648% | +$46.3M | 0.02% | 635 |
|
|
2020
Q2 | $5.12M | Buy |
57,293
+9,992
| +21% | +$892K | ﹤0.01% | 2018 |
|
|
2020
Q1 | $2.95M | Buy |
47,301
+1,050
| +2% | +$65.4K | ﹤0.01% | 2096 |
|
|
2019
Q4 | $3.53M | Buy |
+46,251
| New | +$3.53M | ﹤0.01% | 2207 |
|